X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (110979) 110979
Newsletter (2341) 2341
Book Chapter (672) 672
Newspaper Article (491) 491
Magazine Article (403) 403
Dissertation (235) 235
Conference Proceeding (108) 108
Book / eBook (87) 87
Web Resource (71) 71
Publication (51) 51
Reference (34) 34
Government Document (31) 31
Book Review (24) 24
Trade Publication Article (7) 7
Paper (6) 6
Journal / eJournal (4) 4
Streaming Video (2) 2
Microfilm (1) 1
Report (1) 1
Video Recording (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (74046) 74046
male (52162) 52162
hyperplasia (43856) 43856
female (36030) 36030
middle aged (27115) 27115
aged (22383) 22383
adult (21262) 21262
animals (20838) 20838
urology & nephrology (10379) 10379
benign prostatic hyperplasia (9095) 9095
pathology (7944) 7944
aged, 80 and over (7489) 7489
rats (7445) 7445
surgery (7444) 7444
adolescent (7211) 7211
cancer (7195) 7195
diagnosis, differential (6975) 6975
mice (6788) 6788
oncology (6567) 6567
prostate (6241) 6241
hyperplasia - pathology (6218) 6218
expression (6039) 6039
child (6020) 6020
immunohistochemistry (5806) 5806
endocrinology & metabolism (5661) 5661
prostatic hyperplasia - surgery (5631) 5631
diagnosis (5549) 5549
hypertrophy (5511) 5511
research (5307) 5307
treatment outcome (5123) 5123
retrospective studies (4722) 4722
biopsy (4479) 4479
time factors (4431) 4431
prostatic hyperplasia - pathology (4189) 4189
analysis (4158) 4158
follow-up studies (4109) 4109
risk factors (4019) 4019
prostatic hyperplasia - complications (4017) 4017
carcinoma (3938) 3938
prostatic hyperplasia - drug therapy (3692) 3692
prostate cancer (3643) 3643
tumors (3547) 3547
child, preschool (3496) 3496
intimal hyperplasia (3288) 3288
prostate - pathology (3263) 3263
disease (3238) 3238
inflammation (3211) 3211
cell biology (3184) 3184
men (3169) 3169
medicine & public health (3122) 3122
radiology, nuclear medicine & medical imaging (3114) 3114
care and treatment (3089) 3089
medicine, general & internal (3042) 3042
prostatic hyperplasia (3037) 3037
prostatic neoplasms - pathology (3026) 3026
prospective studies (2987) 2987
infant (2882) 2882
prostatic hyperplasia - diagnosis (2845) 2845
prognosis (2776) 2776
disease models, animal (2769) 2769
peripheral vascular disease (2741) 2741
ultrasonography (2739) 2739
health aspects (2697) 2697
proliferation (2679) 2679
cardiac & cardiovascular systems (2645) 2645
prostatectomy (2642) 2642
pregnancy (2610) 2610
urology (2560) 2560
abridged index medicus (2506) 2506
obstetrics & gynecology (2500) 2500
cells (2480) 2480
lesions (2457) 2457
biochemistry & molecular biology (2447) 2447
apoptosis (2433) 2433
mutation (2413) 2413
tunica intima - pathology (2397) 2397
pharmacology & pharmacy (2378) 2378
infant, newborn (2372) 2372
gene expression (2355) 2355
cell proliferation (2351) 2351
cells, cultured (2349) 2349
liver - pathology (2333) 2333
pediatrics (2330) 2330
gastroenterology & hepatology (2284) 2284
management (2252) 2252
risk (2252) 2252
prostatic hyperplasia - metabolism (2222) 2222
medicine, research & experimental (2216) 2216
growth (2203) 2203
congenital adrenal-hyperplasia (2201) 2201
restenosis (2185) 2185
congenital adrenal hyperplasia (2184) 2184
magnetic resonance imaging (2141) 2141
prostatic hyperplasia - therapy (2140) 2140
research article (2122) 2122
adenocarcinoma - pathology (2118) 2118
prevalence (2110) 2110
sensitivity and specificity (2106) 2106
therapy (2104) 2104
liver (2071) 2071
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (59) 59
Online Resources - Online (17) 17
Collection Dvlpm't (Acquisitions) - Closed Orders (6) 6
Collection Dvlpm't (Acquisitions) - Vendor file (4) 4
Scarborough Hospital - Online (2) 2
UTL at Downsview - May be requested (2) 2
Baycrest Hospital - Wellness Library (1) 1
Lakeridge Health Sciences - Oshawa (1) 1
Markham Stouffville Hospital - Stacks (1) 1
Media Commons - Audio Visual (1) 1
Media Commons - Microtexts (1) 1
Robarts - Stacks (1) 1
Scarborough Hospital - General (1) 1
Scarborough Hospital - Hospital Department (1) 1
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (1) 1
Thomas Fisher Rare Book - Rare Book (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (98068) 98068
German (3938) 3938
French (3269) 3269
Japanese (2664) 2664
Russian (2221) 2221
Spanish (1872) 1872
Italian (1464) 1464
Chinese (1349) 1349
Polish (511) 511
Portuguese (391) 391
Korean (382) 382
Czech (257) 257
Hungarian (198) 198
Dutch (154) 154
Turkish (150) 150
Danish (123) 123
Bulgarian (107) 107
Romanian (107) 107
Swedish (92) 92
Croatian (72) 72
Norwegian (69) 69
Slovak (52) 52
Ukrainian (42) 42
Hebrew (41) 41
Serbian (41) 41
Finnish (29) 29
Persian (23) 23
Lithuanian (15) 15
Greek (14) 14
Bosnian (8) 8
Slovenian (5) 5
Arabic (4) 4
Thai (4) 4
Afrikaans (3) 3
Icelandic (3) 3
Indonesian (2) 2
Azerbaijani (1) 1
Breton (1) 1
Estonian (1) 1
Welsh (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


PLoS ONE, ISSN 1932-6203, 04/2013, Volume 8, Issue 4, p. e59449
Journal Article
The journal of clinical endocrinology and metabolism, ISSN 1945-7197, 2018, Volume 103, Issue 11, pp. 4043 - 4088
Journal Article
European Urology, ISSN 0302-2838, 2011, Volume 60, Issue 4, pp. 809 - 825
Abstract Context This review focuses on the relationship among sexual dysfunction (SD), lower urinary tract symptoms (LUTS) due to benign prostatic hyperplasia... 
Urology | PDE5 | PDE5-i | IIEF | IPSS | Benign prostatic hyperplasia | LUTS | BPH | Prostate | EjD | Age | NITRIC-OXIDE SYNTHASE | SELECTIVE ALPHA-1A-BLOCKER | HOLMIUM LASER ENUCLEATION | RHOA/RHO-KINASE | MEDICAL THERAPY | DOUBLE-BLIND | UROLOGY & NEPHROLOGY | QUALITY-OF-LIFE | TRANSURETHRAL RESECTION | ERECTILE DYSFUNCTION | AGING MEN | ED | Meta-Analysis as Topic | Prevalence | Sexual Dysfunction, Physiological - physiopathology | Humans | Sexual Dysfunction, Physiological - drug therapy | Male | Lower Urinary Tract Symptoms - epidemiology | Prostatic Hyperplasia - complications | Prostatic Hyperplasia - epidemiology | Lower Urinary Tract Symptoms - drug therapy | rho-Associated Kinases - metabolism | Adrenergic alpha-1 Receptor Antagonists - therapeutic use | Lower Urinary Tract Symptoms - etiology | Lower Urinary Tract Symptoms - surgery | Phosphodiesterase 5 Inhibitors - therapeutic use | Drug Therapy, Combination | Prostatic Hyperplasia - drug therapy | Atherosclerosis - drug therapy | Lower Urinary Tract Symptoms - physiopathology | Clinical Trials as Topic | Prostatic Hyperplasia - surgery | Sexual Dysfunction, Physiological - etiology | Sexual Dysfunction, Physiological - surgery | Cyclic GMP - metabolism | Sexual Dysfunction, Physiological - epidemiology | Prostatic Hyperplasia - physiopathology | Nitric Oxide - metabolism | Medical colleges | Sexual disorders | Analysis | Hypertrophy
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2010, Volume 362, Issue 13, pp. 1192 - 1202
Dutasteride, an inhibitor of 5α-reductase in the prostate, was tested in a large, randomized trial to determine its ability to prevent prostate cancer. Over... 
MODELING APPROACH | MEDICINE, GENERAL & INTERNAL | DESIGN | THERAPY | 5-ALPHA-REDUCTASE INHIBITOR DUTASTERIDE | SENSITIVITY | FINASTERIDE | GRADE | HYPERPLASIA | PROGRESSION | PREVENTION TRIAL | Enzyme Inhibitors - adverse effects | Prostatic Neoplasms - pathology | Prostatic Hyperplasia - pathology | Double-Blind Method | Erectile Dysfunction - chemically induced | Humans | Middle Aged | 5-alpha Reductase Inhibitors | Male | Risk | Treatment Outcome | Azasteroids - therapeutic use | Enzyme Inhibitors - therapeutic use | Prostate-Specific Antigen - blood | Azasteroids - adverse effects | Prostate - pathology | Prostatic Neoplasms - genetics | Biopsy | Protein Isoforms | Dutasteride | Aged | Prostatic Neoplasms - prevention & control | Prostatic Hyperplasia - drug therapy | Heart Failure - chemically induced | Usage | Diagnosis | Health aspects | Prostate cancer | Risk factors | Patient safety | Age | Men | Tumors | Prostate-Specific Antigen | Erectile Dysfunction | Enzyme Inhibitors | Testosterone 5-alpha-Reductase | Prostatic Hyperplasia | Life Sciences | Prostatic Neoplasms | Azasteroids | Heart Failure | Prostate | Cancer | pathology | genetics | Urologi och njurmedicin | chemically induced | drug therapy | prevention & control | blood | adverse effects | Cancer and Oncology | Urology and Nephrology | therapeutic use | Cancer och onkologi
Journal Article
7.